Delivery Order SPE2DR25D3301-SPE2DR26F19RD
- Not listed
- The Defense Logistics Agency awarded a $25,890.84 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This firm fixed price contract was competitively awarded without a set-aside designation and is scheduled for completion by October 14, 2025. The award was announced on September 22, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $17,260.58 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside provisions on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order operates under a firm fixed-price arrangement and is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 24, 2025, and was competitively awarded without any set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The order carries a ceiling value of $17,181.16 under a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award represents a non-set-aside, competitively awarded contract issued to the Conshohocken, Pennsylvania-based pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pulmonary fibrosis treatment medication, with a ceiling value of $18,106.32. The award, issued on November 24, 2025, is scheduled for completion by December 16, 2025, and utilizes firm fixed-price pricing with no set-aside designation. Performance of this delivery order will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for 60-count capsules of Ofev 100 mg, a pharmaceutical product used primarily in the treatment of pulmonary fibrosis. The contract was competitively awarded on November 14, 2025, with an ultimate completion date of December 8, 2025, and involves firm fixed price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,355.26 under a firm fixed-price contract. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialized pharmaceutical used primarily in the treatment of pulmonary fibrosis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a $18.1K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of January 5, 2026. This delivery order leverages AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19RDDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This competitively awarded, non-set-aside delivery order carries a ceiling value of approximately $18.2K with firm fixed pricing and is scheduled for completion by January 9, 2026. The award was announced on December 17, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition, combined with its extensive portfolio of medical product deliveries, positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 12/16/25 |